Archives
- 2026-11
- 2026-10
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
Amitriptyline HCl: Protocol and QC Guide
2026-09-17
Amitriptyline HCl (SKU B2231) provides a defined small-molecule reference for receptor-inhibition profiling, solution preparation, and controlled neuropharmacology research workflows. It is intended for assay development and in vitro mechanistic studies, not as evidence of clinical efficacy or a substitute for assay-specific validation.
Alosetron: 5-HT3 Receptor Antagonist Workflows
2026-09-17
Use Alosetron as a selective pharmacological probe for serotonin-driven gastrointestinal motility, visceral pain, and epithelial homeostasis assays. This workflow positions 5-HT3 blockade alongside, rather than in place of, the CDC42–YAP–EGF–mTOR mechanisms identified in intestinal stem-cell research.
BBB Permeability and Lysosomal Trapping Correction
2026-09-16
This 2025 study developed a high-throughput LLC-PK1-MOCK/MDR1 Transwell model that links in vitro permeability with unbound brain distribution and explicitly corrects lysosomal trapping. Across 41 compounds, the approach distinguished passive diffusion, P-gp-mediated efflux, and intracellular sequestration, supporting more reliable early CNS screening according to the reference study.
Sumatriptan Succinate in Inflammation Research
2026-09-16
Learn how to deploy Sumatriptan as a 5-HT1 receptor agonist in serotonergic, neuroinflammatory, and metabolism workflows. This practical guide connects receptor-level assays with cytokine, CGRP, NF-κB, and ischemia/reperfusion readouts while emphasizing salt-form verification, dose design, and reproducibility.
Ziprasidone Augmentation in Anxious Depression
2026-09-15
This post-hoc moderator analysis examined whether baseline anxious depression altered the effects of ziprasidone added to escitalopram in an 8-week randomized trial. Depression outcomes were similar in patients with and without anxious depression, while the apparent anxiety benefit in highly anxious participants was not clinically significant, limiting subgroup-based conclusions.
RRP Restores Lipid Metabolism in Hepatic IRI
2026-09-15
A 2024 Journal of Ethnopharmacology study identifies lipid metabolic restoration as a central mechanism by which Radix Rehmanniae Praeparata extracts reduce hepatic ischemia-reperfusion injury. Its evidence connects AMPK activation with suppression of SCAP-SREBP2 cholesterol synthesis and enhancement of LXRα-dependent cholesterol efflux, providing a useful framework for lipid metabolism research.
EZ Cap Cy5 Firefly Luciferase mRNA Workflow
2026-09-14
This dual-reporter transcript separates mRNA uptake from functional protein expression, making it useful for carrier screening, translation efficiency assays, and intracellular trafficking studies. Cy5 fluorescence provides an early delivery readout, while Firefly Luciferase supports sensitive endpoint or longitudinal bioluminescence measurements.
iPSC Cardiomyocytes for Chemical Risk Characterization
2026-09-14
Tsai and colleagues show that combining functional phenotypes with transcriptomic responses in human iPSC-derived cardiomyocytes can improve chemical hazard prioritization and mechanistic interpretation. Across 464 chemicals, the integrated workflow connected concentration-response activity with points of departure and exposure-based risk characterization without relying on electrophysiology alone.
Tetrandrine: An Evidence-to-Assay Guide
2026-09-13
Tetrandrine is a calcium-channel-modulating alkaloid best used as a carefully controlled mechanistic perturbation tool. This evidence-to-assay guide connects product handling, ion-channel experiments, and the limits of computational antiviral evidence.
Lamotrigine Research Workflows for Ion Channels
2026-09-12
Build reproducible Lamotrigine assays for neuronal sodium-channel, cardiac electrophysiology, serotonin, and CYP19 workflows. This guide emphasizes solvent control, concentration design, orthogonal readouts, and troubleshooting for translational epilepsy and safety studies.
Copper-Catalyzed Thioazafluoranthene Synthesis
2026-09-11
Chen and co-workers reported an air-compatible copper-catalyzed radical cascade that converts N-tosyl-8-ethynyl-1-naphthylamines into sulfur- and nitrogen-doped fluoranthene frameworks. The method combines broad synthetic utility with a notable fluorescence response, including a 143 nm Stokes shift for amino-linked products in dilute tetrahydrofuran.
PGE2-Driven Schwann Cell Dedifferentiation in PDAC
2026-09-11
Wang and colleagues identify a paracrine PTGES–PGE2–Schwann cell axis that links pancreatic ductal adenocarcinoma to Schwann cell dedifferentiation and perineural invasion. By combining clinical transcriptomic analyses with coculture and three-dimensional models, the study implicates LIF and ADAMTS-1 as downstream factors that support neural remodeling and tumor invasion.
Angiotensin Peptides Enhance SARS-CoV-2 Spike Binding
2026-09-10
A 2025 study found that naturally occurring angiotensin peptides can increase SARS-CoV-2 spike protein binding to AXL, with selected shorter and N-terminally truncated peptides showing stronger activity than longer parent sequences. The work identifies peptide length and residue chemistry as variables for receptor-binding studies, while also highlighting that the findings remain at the biochemical assay stage rather than demonstrating altered infection or clinical disease.
Schizophrenia Risk Pathways in Developing Neurons
2026-09-10
Liu et al. show that schizophrenia-associated GWAS loci converge on different biological pathways in developing cortical interneurons and glutamatergic neurons. Their cell-type-resolved iPSC model links interneuron risk genes to PKC hyperactivity and arborization defects, while glutamatergic-neuron risk genes converge on ion transport and calcium-current abnormalities.
TSPAN18–STIM1 Signaling in Prostate Cancer Bone Metastasis
2026-09-09
Zhou et al. identify TSPAN18 as a stabilizer of STIM1 that limits TRIM32-mediated ubiquitination and amplifies store-operated calcium entry in prostate cancer. The study connects this protein-quality-control mechanism to migration, invasion, bone metastasis, and adverse clinical features, providing a mechanistic framework for prostate cancer research.
8029 records 8/536 page Previous Next First page 上5页 678910 下5页 Last page